Severe abdominal pain as a presenting symptom of probable catastrophic antiphospholipid syndrome

Pediatrics

Volumn 130, Issue 1, 2012, Pages

  Haskin, Orly ^a   Amir, Jacob ^a   Schwarz, Michael ^a   Schonfeld, Tommy ^a   Nahum, Elhanan ^a   Ling, Galina ^b   Prais, Dario ^a   Harel, Liora ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Abdominal pain; Adolescents; Catastrophic antiphospholipid syndrome

Indexed keywords

ACETYLSALICYLIC ACID; AMYLASE; ANTIBIOTIC AGENT; BOSENTAN; C REACTIVE PROTEIN; CORTICOSTEROID; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; LOW MOLECULAR WEIGHT HEPARIN; PREDNISONE; RITUXIMAB; SILDENAFIL; STEROID; TRIACYLGLYCEROL LIPASE; TROPONIN; WARFARIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG PULSE THERAPY; ECHOCARDIOGRAPHY; EPIGASTRIC PAIN; ERYTHROCYTE SEDIMENTATION RATE; FATTY LIVER; FEMALE; FEVER; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEPARINIZATION; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; LUNG EMBOLISM; LUNG PRESSURE; MALE; MULTIPLE CYCLE TREATMENT; PARTIAL THROMBOPLASTIN TIME; PEDIATRICS; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; PULMONARY HYPERTENSION; PYELONEPHRITIS; SPLENECTOMY; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN; THROMBOSIS; TREATMENT OUTCOME; VOMITING;

ABDOMEN, ACUTE; ADOLESCENT; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; FEMALE; HUMANS; MALE; THROMBOSIS;

EID: 84863506631     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-1694     Document Type: Article

References (15)

1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346(10):752-763 (Pubitemid 34983997)
2. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol. 1992;19(4):508-512
3. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore). 1998;77(3): 195-207 (Pubitemid 28290020)
4. Cervera R, Font J, Gómez-Puerta JA, et al Catastrophic Antiphospholipid Syndrome Registry Project Group. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis. 2005;64(8):1205-1209 (Pubitemid 41113358)
5. Cimaz R, Descloux E. Pediatric antiphospholipid syndrome. Rheum Dis Clin North Am. 2006;32(3):553-573 (Pubitemid 44118677)
6. Avcin T, Cimaz R, Silverman ED, et al. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics. 2008; 122(5). Available at: www.pediatrics.org/cgi/ content/full/122/5/e1100
7. Asherson RA, Cervera R, de Groot PG, et al Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7): 530-534 (Pubitemid 36890145)
8. Cervera R, Bucciarelli S, Plasín MA, et al Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum On Antiphospholipid Antibodies). Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry." J Autoimmun. 2009;32(3-4):240-245
9. Cervera R; CAPS Registry Project Group. Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry.'Lupus. 2010;19(4):412-418
10. Cervera R, Espinosa G, Cordero A, et al Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group. Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS. Semin Arthritis Rheum. 2007;36(5): 287-296 (Pubitemid 46517629)
11. Uthman I, Khamashta M. The abdominal manifestations of the antiphospholipid syndrome. Rheumatology (Oxford). 2007;46 (11):1641-1647 (Pubitemid 350018483)
12. Ortega-Hernandez OD, Agmon-Levin N, Blank M, Asherson RA, Shoenfeld Y. The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence. J Autoimmun. 2009;32(1):1-6
13. Rubenstein E, Arkfeld DG, Metyas S, Shinada S, Ehresmann S, Liebman HA. Rituximab treatment for resistant antiphospholipid syndrome. J Rheumatol. 2006;33(2):355-357 (Pubitemid 43209314)
14. Nageswara Rao AA, Arteaga GM, Reed AM, Gloor JM, Rodriguez V. Rituximab for successful management of probable pediatric catastrophic antiphospholipid syndrome. Pediatr Blood Cancer. 2009;52(4):536-538
15. Iglesias-Jimenez E, Camacho-Locillo M, Falcon-Neyra D, Lirola-Cruz J, Neth O. Infant with probable catastrophic antiphospholipid syndrome successfully managed with rituximab. Pediatrics. 2010;125(6). Available at: www.pediatrics.org/cgi/content/full/125/6/e1523